NOVTU — Novanta Inc. Tangible Equity Units

Summary of Novanta Inc. Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue Growth: Novanta reported a 10% increase in revenue year-over-year, with 3% organic growth.
• Bookings: Bookings surged by 37% year-over-year, achieving a book-to-bill ratio of 1.10.
• Profitability: Adjusted EBITDA rose 14% to $57 million, with an adjusted EBITDA margin of 22%, up 70 basis points year-over-year. Adjusted diluted EPS increased by 9% to $0.81.
• Cash Flow: Operating cash flow increased by 63% year-over-year to $52 million, with cash flow conversion exceeding 200% of net income.
• Gross Margins: Adjusted gross margin was 45.6%, slightly down from 46% in Q1 2025 due to cost pressures.

2. Strategic Updates and Business Highlights

• Market Performance: All business segments reported double-digit bookings growth, with notable strength in Advanced Surgery, Robotics & Automation, and Precision Manufacturing.
• Product Innovation: New product revenue grew by 50% year-over-year, contributing to a Vitality Index of 27% of total sales.
• Long-term Strategy: Novanta aims to capitalize on high-growth markets such as AI-driven Robotics & Automation, Precision Medicine, and digital manufacturing, targeting a $4 billion market opportunity by 2030.
• Acquisitions: The company is actively pursuing acquisitions to enhance its portfolio, with a strong pipeline of mid- to larger opportunities.

3. Forward Guidance and Outlook

• 2026 Guidance: Novanta raised its revenue forecast to $1,040 million to $1,055 million, projecting reported growth of over 7% and organic growth of up to 6%.
• Q2 Expectations: For Q2 2026, the company anticipates revenue of $259 million to $264 million, reflecting year-over-year organic growth of 6% to 8%.
• Profitability Projections: Adjusted EBITDA for Q2 is expected to be between $58 million and $62 million, with an EBITDA margin of approximately 23%.

4. Bad News, Challenges, or Points of Concern

• Cost Pressures: The company faced higher freight and tariff costs, which negatively impacted gross margins. Adjustments to pricing and surcharges are underway to mitigate these effects.
• Geopolitical Risks: Ongoing trade dynamics and geopolitical tensions are being monitored closely, as they could impact future performance.
• U.S. Market Decline: Sales in the U.S. were down year-over-year, attributed to shifts in customer production locations rather than a decline in end-market demand.

5. Notable Q&A Insights

• GenAI Infrastructure: Approximately 15% of total revenue is linked to applications driven by GenAI investments, with expected growth rates accelerating throughout the year.
• NVIDIA Partnership: Novanta's selection for the NVIDIA AI Systems Inspection Lab enhances its credibility in the robotics space, although meaningful revenue impacts from this partnership are anticipated to materialize in 2027.
• Bookings vs. Revenue: The strong bookings growth is expected to translate into revenue within the next 12 months, with a typical lag of two to three quarters.
• Regional Manufacturing Strategy: The ongoing consolidation of manufacturing facilities is expected to improve gross margins in the second half of the year.

Overall, Novanta's Q1 2026 results reflect strong growth and operational momentum, although challenges related to cost pressures and geopolitical risks remain. The company is optimistic about its strategic direction and market opportunities moving forward.